In this paper we report an NMR investigation on the chiral gemini surfactant ( 2S, 3S )-2,3-dimethoxy-1,4-bis( N -hexadecyl- N, N -dimethylammonium)butane dibromide ( 1 ), carried out to study the aggregation in various solvents. If the aggregation equilibrium of 1 can be described by the mass action law model, by observing the variation of chemical shift with respect to [ 1 ], we can obtain the aggregation number n . In CDCl 3 the values are n = 2 and 19 ± 3, at low and high [ 1 ], respectively, indicating that 1 is present in dimeric assemblies and as reversed micelles. In CD 3 OD, despite evidence that 1 is under aggregating conditions, the model does not hold; 1 should form a relatively flexible structure, because in the 13 C NMR spectra 1 J ( 13 C, 14 N) coupling is observed ( 1 J = 3.4 Hz). 1 is scarcely soluble in D 2 O; in the 1 H NMR spectrum of 1 × 10 - 3 M 1, the signals relative to the tails and to one of the NCH 3 groups disappear, while the other head group signals are well resolved, indicating the presence of large assemblies. These large aggregates are confirmed by preliminary experiments of dynamic laser light scattering. The signals of the two NCH 3 groups are very different in all the solvents investigated. This result can be interpreted in terms of an aggregate conformation in which they undergo different environments.
No takes yet. Share an insight, caveat, or question.
Luchetti et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: